A comparison of autofluorescence bronchoscopy and videobronchoscopy for the detection of precancerous lesions in patients with suspected lung cancer
Completed
- Conditions
- CancerCancer: LungLung
- Registration Number
- ISRCTN13176647
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2006 Update - Department of Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Not provided at time of registration
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does autofluorescence bronchoscopy enhance detection of precancerous lung lesions compared to standard videobronchoscopy?
What molecular mechanisms underlie autofluorescence bronchoscopy's ability to identify early lung cancer changes?
Are there specific biomarkers that predict better detection rates with autofluorescence bronchoscopy in lung cancer screening?
What adverse events were documented in ISRCTN13176647 using autofluorescence bronchoscopy for lung lesion detection?
How does autofluorescence bronchoscopy compare to other advanced imaging modalities in diagnosing lung cancer precursors?